Skip to main content
. Author manuscript; available in PMC: 2020 Apr 28.
Published in final edited form as: Liver Transpl. 2019 Jan;25(1):14–24. doi: 10.1002/lt.25346

Table 4:

Multivariable models for LOS in NASH and ALD cohorts

NASH Change in average LOS* 95% CI p-value
Age (per 10 yrs) 2.85 (−1.17, 6.86) 0.16
Sex (F vs M) −1.41 (−8.67, 5.86) 0.70
MELD Score (per 1 point) 0.19 (−0.29, 0.68) 0.42
BMI (per 1 kg/m2) 0.46 (−0.09, 1.01) 0.10
Muscle mass (per 1 cm2/m2) −0.28 (−0.78, 0.21) 0.25
Myosteatosis (per HU) 0.10 (−0.32, 0.52) 0.65
Frailty deficit index (per 0.1 unit) 2.72 (−0.01, 5.45) 0.05
ALD Change in average LOS* 95% CI p-value
Age (per 10 yrs) 1.43 (−2.23, 5.09) 0.44
Sex (F vs M) −3.90 (−11.19, 3.40) 0.29
MELD Score (per 1 point) 0.31 (−0.29, 0.91) 0.31
BMI (per 1 kg/m2) −0.79 (−1.62, 0.04) 0.06
Muscle mass (per 1 cm2/m2) 0.21 (−0.28, 0.69) 0.40
Myosteatosis (per HU) −0.35 (−0.77, 0.07) 0.10
Frailty deficit index (per 0.1 unit) 1.76 (−1.18, 4.70) 0.24
*

The estimated difference in LOS (i.e. for age: For every 10-year increase in age the average LOS increases by 2.85 days and 1.43 days in patients with NASH and ALD, respectively); LOS- length of stay